EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 11500A |
Device Problems
Fluid/Blood Leak (1250); Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
|
Patient Problems
Stroke/CVA (1770); Endocarditis (1834); Insufficient Information (4580)
|
Event Type
Injury
|
Manufacturer Narrative
|
The device was explanted > 0 days for unknown reasons.Although there are multiple root causes, valves are typically explanted because they are not functioning optimally.In this case, intervention has been performed.Additional information and product return for evaluation have been requested.However, there has been no response at this time.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
Edwards lifesciences maintains an implant patient registry (ipr).This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint".The information reported may or may not be related to the edwards device.It was reported via the implant patient registry that this inspiris resilia valve model 11500a25 was explanted from the aortic position after an implant duration of six (6) months for unknown reason.A valve model 11500a23 was implanted in replacement.This case involved a patient who was 56 years old at the time of the reported event and who was noted as to be in recovery after the procedure.
|
|
Manufacturer Narrative
|
H10: additional narrative: based on the additional information obtained, this event is no longer considered reportable and this correction is being submitted.
|
|
Event Description
|
Edwards lifesciences maintains an implant patient registry (ipr).This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint".The information reported may or may not be related to the edwards device.It was reported via the implant patient registry that this inspiris resilia valve model 11500a25 was explanted from the aortic position after an implant duration of four (4) months due to endocarditis leading to regurgitation.The prosthetic valve was found to have multiple small vegetations.Two months after implant, patient was feeling unwell with fevers and night sweats and was found to have positive blood culture.The infecting organism of endocarditis was enterococcus faecalis after an urinary tract infection (uti).Patient was admitted to hospital and also found to have occipital stroke with his enterococcus faecalis bacteremia.Patient finished six weeks of antibiotics and was readmitted two months later with positive cultures.A valve model 11500a23 was implanted in replacement with no complications.The patient was noted as to be in recovery and feeling well after the procedure and was discharged on pod #30.
|
|
Search Alerts/Recalls
|
|
|